Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Akari Therapeutics Announces Proposed Public Offering of American Depositary Shares
-
Akari Therapeutics to Present at the 37th Annual Canaccord Genuity Growth Conference
-
Pre-Open Stock Movers 05/31: (DAC) (JILL) (ETRM) Higher; (GEMP) (AKTX) (KORS) Lower (more...)
-
Akari Therapeutics to Attend Upcoming Investor Conferences in February
-
Akari Therapeutics to Present at the Canaccord Genuity 36th Annual Growth Conference
-
Canaccord Genuity Starts Akari Therapeutics (AKTX) at Buy
-
Akari Therapeutics to Participate in the 2016 Canaccord Genuity Rare Disease, BioPharma One-On-One Day

